FDA approves Regeneron’s Covid-19 antibody treatment

The FDA granted emergency use authorization for Regeneron’s antibody treatment, which President Trump received when he battled the coronavirus last month. Pfizer and BioNTech’s Covid-19 vaccine is pending approval.